Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
As of June 2026, tesamorelin is FDA-approved only for HIV-associated lipodystrophy (sold as EGRIFTA WR and EGRIFTA SV), ipamorelin is not FDA-approved, and the blend is not FDA-approved
Your provider can assess your individual risk factors, recommend safer alternatives, monitor liver function if needed, and discuss N-acetylcysteine (NAC) supplementation if appropriate for your situation
Response varies considerably between individuals
Do not carry these exact dose figures over to a different GHRH partner
US$ 29.25
US$ 22.23
US$ 20.83
US$ 20.03
US$ 28.59
US$ 29.01
US$ 22.37
US$ 24.85
US$ 25.39
US$ 22.57
US$ 22.85
US$ 28.33
